AVALO THERAPEUTICS INC (AVTX) Stock Balance Sheet
NASDAQ:AVTX • US05338F3064
Current stock price
13.52 USD
+0.1 (+0.75%)
Last:
| MRQ (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 26.96M | 134.55M | 7.42M | 13.17M | 54.59M | |||
| Marketable Securities | 84.65M | N/A | N/A | N/A | N/A | |||
| Receivables | N/A | 611.00K | 136.00K | 1.92M | 4.80M | |||
| Inventories | N/A | N/A | 0.00 | 20.00K | 40.00K | |||
| Other Current Assets | 2.23M | 3.73M | 844.00K | 1.31M | 2.42M | |||
| Total Current Assets | 113.85M | 138.89M | 8.39M | 16.42M | 61.85M | |||
| Non-Current Assets | ||||||||
| PPE Net | 542.00K | 1.21M | 1.97M | 2.41M | 2.70M | |||
| Goodwill | 10.50M | 10.50M | 10.50M | 14.41M | 14.41M | |||
| Intangibles | N/A | N/A | N/A | 0.00 | 40.00K | |||
| Other Non-Current Assets | 210.00K | 131.00K | 131.00K | 130.00K | 1.23M | |||
| Total Non-Current Assets | 11.25M | 11.84M | 12.60M | 16.95M | 18.36M | |||
| TOTAL ASSETS | 125.10M | 150.73M | 20.99M | 33.37M | 80.21M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 327.00K | 327.00K | 0.00 | 5.93M | N/A | |||
| Accrued Expenses | 7.17M | 5.99M | 4.17M | 12.71M | 16.14M | |||
| Accounts Payable | 474.00K | 283.00K | 446.00K | 2.88M | 3.37M | |||
| Other Current Liabilities | 0.00 | 360.00K | 0.00 | 600.00K | 380.00K | |||
| Total Current Liabilities | 7.97M | 6.96M | 4.62M | 22.11M | 19.89M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 2.00M | 2.00M | 2.00M | 13.49M | 32.83M | |||
| Deferred Taxes/Income | 304.00K | 270.00K | 155.00K | 140.00K | 110.00K | |||
| Other Non-Current Liabilities | 23.28M | 8.47M | 6.92M | 8.54M | 4.30M | |||
| Total Non-Current Liabilities | 25.58M | 10.74M | 9.07M | 22.17M | 37.24M | |||
| TOTAL LIABILITIES | 33.55M | 17.70M | 13.69M | 44.28M | 57.13M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -434.80M | -370.26M | -335.13M | -303.82M | -262.17M | |||
| Additional Paid In Capital | 526.29M | 503.29M | 342.44M | 292.90M | 285.14M | |||
| Common Shares | 18.00K | 10.00K | 1.00K | 10.00K | 110.00K | |||
| Other Shareholders' Equity | 41.00K | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 17.83M | 10.47M | 801.80K | 9.43M | 9.40M | |||
| Tangible Book Value per Share | 4.55 | 11.70 | -3.99 | -2.69 | 0.92 | |||
| Total Shareholders' Equity | 91.55M | 133.03M | 7.30M | -10.92M | 23.08M | |||
| TOTAL LIABILITIES AND EQUITY | 125.10M | 150.73M | 20.99M | 33.37M | 80.21M | |||
| Statistics | ||||||||
| Debt/Equity | 0.02 | 0.02 | 0.27 | -1.24 | 1.42 | |||
| Current Ratio | 14.28 | 19.96 | 1.82 | 0.74 | 3.11 | |||
| Return On Assets (ROA) | -79.77% | -23.31% | -150.26% | -124.84% | -105.20% | |||
| Return On Equity (ROE) | -109.00% | -26.41% | -431.87% | N/A | -365.60% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21